Log in

OSE OSE Immunotherapeutics SA EURONEXT · France

OSE Immunotherapeutics SA (OSE) news

OSE Immunotherapeutics SA is a public biotech or pharmaceutical company listed on EURONEXT under the ticker OSE, recorded under France. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest OSE Immunotherapeutics SA news

We have not published a story on OSE Immunotherapeutics SA yet. When there is news, it will appear here.

Questions about OSE Immunotherapeutics SA

What is the ticker symbol of OSE Immunotherapeutics SA?

OSE Immunotherapeutics SA trades under the ticker OSE on EURONEXT.

Where is OSE Immunotherapeutics SA listed?

OSE Immunotherapeutics SA is listed on EURONEXT. Our directory also records these other listings: GETTEX:6OP; LSE:0RAD; LSX:A14QXP.

Which country or territory is OSE Immunotherapeutics SA listed under?

Our directory records OSE Immunotherapeutics SA under France.

What does OSE Immunotherapeutics SA do?

Our directory classifies OSE Immunotherapeutics SA as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of OSE Immunotherapeutics SA?

The ISIN recorded for OSE Immunotherapeutics SA is FR0012127173.

Does aibio.space cover OSE Immunotherapeutics SA?

aibio.space lists OSE Immunotherapeutics SA among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to OSE Immunotherapeutics SA?

Companies in our directory listed in the same country and business area as OSE Immunotherapeutics SA: Sensorion SA, MaaT Pharma, Adocia SA, Nanobiotix SA, Innate Pharma SA, Sanofi SA.

Investor discussion: OSE Immunotherapeutics SA

Members talk about OSE Immunotherapeutics SA (OSE). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open EURONEXT:OSE on TradingView.

Listing details

OSE Immunotherapeutics SA is a public biotech or pharmaceutical company listed on EURONEXT under the ticker OSE, recorded under France. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
OSE Immunotherapeutics SA
Ticker
OSE
Listing
EURONEXT
Country or territory
France
Business scope
Pharmaceuticals: Major
ISIN
FR0012127173
Other listed symbols
GETTEX:6OP; LSE:0RAD; LSX:A14QXP
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.